$BIIB News AT&T, Yelp shares decline after earnings

New Post Public Reply Private Reply Replies (0) Message Board

Oct 23, 2014 at 10:37 AM

$BIIB News

AT&T, Yelp shares decline after earnings 5:48 p.m. Oct. 22, 2014 - Sue Chang
U.S. stocks wither; S&P 500 ends 4-day win steak 4:39 p.m. Oct. 22, 2014 - Carla Mozee
Updates, advisories and surprises 4:31 p.m. Oct. 22, 2014 - MarketWatch
Biogen shares drop on Tecfidera patient death 11:48 a.m. Oct. 22, 2014 - Russ Britt
Icahn says buying Apple is a ‘no-brainer’, and a first-ever for the VIX 11:37 a.m. Oct. 22, 2014 - Barbara Kollmeyer
Biogen Idec shares slump 7.6% 9:32 a.m. Oct. 22, 2014 - Sue Chang
Biogen shares turn lower; analyst says key MS drug sales missed expectations 8:37 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares turn lower, down 2.7% premarket after Q3 results 8:13 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen beats estimates on strong MS drug sales 7:49 a.m. Oct. 22, 2014 - MarketWatch.com
Biogen shares rally after beating profit expectations, raising outlook 7:15 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen shares gain 0.7% premarket after Q3 results 7:06 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen ups full-year adj. EPS outlook to $13.45-$13.55 vs. FactSet estimate $13.10 7:05 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 net EPS $3.62 vs. $2.05 a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 FactSet sales consensus $2.48 bln 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 sales $2.51 bln vs. $1.83 bln a year ago 7:03 a.m. Oct. 22, 2014 - Tomi Kilgore
Biogen Q3 adj. EPS $3.80 vs. FactSet consensus $3.45 7:02 a.m. Oct. 22, 2014 - Tomi Kilgore
Boeing, AT&T reports due Wednesday; Yahoo up late 6:48 p.m. Oct. 21, 2014 - Sue Chang
More than 1/3 of Dow stocks to report this week 5:30 a.m. Oct. 19, 2014 - Wallace Witkowski
NYSE to expand number of companies on biotech index 5:52 p.m. Oct. 14, 2014 - Wallace Witkowski
14 stocks loved by top-performing fund managers 6:49 a.m. Sept. 18, 2014 - Philip van Doorn

US Stock Futures Rise Ahead Of Earnings, Economic Data 6:41 a.m. Today - benzinga.com
Leading Researchers Join Biogen Idec To Advance Drug Discovery For Neurodegenerative Diseases 6:31 a.m. Today - benzinga.com
EPS Strong; Revenues Weak 2:20 a.m. Today - Seeking Alpha
Watch for This Sign That the Correction Is Over 9:18 p.m. Oct. 22, 2014 - InvestorPlace.com
10-Q: BIOGEN IDEC INC. 5:01 p.m. Oct. 22, 2014 - Edgar Online - (EDG = 10Q, 10K)
Dow Ends Lower After Three-Day Rise 4:32 p.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Biotechs Show Fed Chief's Not Much Of A Stock Analyst 4:01 p.m. Oct. 22, 2014 - Investors Business Daily
Biogen Idec's (BIIB) CEO George Scangos on Q3 2014 Results - Earnings Call Transcript 2:51 p.m. Oct. 22, 2014 - Seeking Alpha
Despite Stock Market Rally Many Opportunities Still Exist 2:20 p.m. Oct. 22, 2014 - TheStreet.com
Biogen's Q3 Earnings Top Estimates, View Raised Again - Analyst Blog 1:10 p.m. Oct. 22, 2014 - Zacks.com
3 Stocks Pulling The Drugs Industry Downward 1:03 p.m. Oct. 22, 2014 - TheStreet.com
Why Boeing Co, Biogen Idec Inc, and Discover Financial Services are Today’s 3 Worst Stocks 12:44 p.m. Oct. 22, 2014 - InvestorPlace.com
Why Biogen Idec (BIIB) Stock Is Tanking Today 12:39 p.m. Oct. 22, 2014 - TheStreet.com
Worries Cloud Biogen’s Results 10:35 a.m. Oct. 22, 2014 - The Wall Street Journal Interactive Edition
Biogen, Thermo Reports Disappoint; Abbott Accelerates 10:18 a.m. Oct. 22, 2014 - Investors Business Daily
Trade-Ideas: Biogen Idec (BIIB) Is Today's Unusual Social Activity Stock 9:52 a.m. Oct. 22, 2014 - TheStreet.com
Biogen drops after earnings call 9:44 a.m. Oct. 22, 2014 - Seeking Alpha
Biogen Idec (BIIB) Q3 2014 Results - Earnings Call Webcast 8:25 a.m. Oct. 22, 2014 - Seeking Alpha
Biogen Takes Breather on Earnings and MS Drug Sales 8:07 a.m. Oct. 22, 2014 - 247WallSt.com
Benzinga's Top #PreMarket Losers 7:43 a.m. Oct. 22, 2014 - benzinga.com

Leading Researchers Join Biogen Idec to Advance Drug Discovery for Neurodegenerative Diseases 7:30 a.m. Today - BusinessWire - BZX
Regulatory Approval, Customer Safety Alert, Patient Support Program Launch, Earnings Releases, and Rating - Research Reports on Medtronic, Covidien, Biogen Idec, Baxter and Express Scripts 8:55 a.m. Oct. 21, 2014 - PR Newswire - PRF
Biogen Idec and Gretchen Rubin Unveil MS BlueprintTM, a New Online Tool to Help People with Multiple Sclerosis Attain Personal Goals 8:01 a.m. Oct. 15, 2014 - BusinessWire - BZX
Presentation of Clinical Data, FDA Approval, Notes Offering, and Market Activity - Research Reports on Biogen Idec, Arrowhead, Salix, HCA and Shire 8:30 a.m. Oct. 13, 2014 - PR Newswire - PRF
Sobi's collaboration partner Biogen Idec files marketing authorisation application for Elocta(TM) (rFVIIIFc) in Europe 3:01 p.m. Oct. 9, 2014 - Thomson Reuters ONE
CORRECTING and REPLACING Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 4:01 p.m. Oct. 8, 2014 - BusinessWire - BZX
Earnings Release Schedules, Data Presentation, Regulatory Approvals, and Strategic Collaboration - Research Reports on Covidien, Biogen, Amgen, Agios and Baxter 8:55 a.m. Oct. 1, 2014 - PR Newswire - PRF
Biogen Idec To Report Third Quarter 2014 Financial Results on October 22, 2014 5:34 p.m. Sept. 25, 2014 - BusinessWire - BZX
Results of Clinical Trials, New Drug Applications, Leadership Appointments, and Scheduled Earnings - Research Reports on Biogen, Salix, Express Scripts, Stryker and Shire 9:25 a.m. Sept. 23, 2014 - PR Newswire - PRF
Biogen Idec Named Global Biotechnology Industry Leader on Dow Jones Sustainability World Index 8:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Olivier Danos Joins Biogen Idec as Senior Vice President, Gene Therapy 7:00 a.m. Sept. 23, 2014 - BusinessWire - BZX
Sobi expands Haemophilia development portfolio - elects to include potentially longer-acting Haemophilia A candidate in collaboration agreement with Biogen Idec 2:01 a.m. Sept. 19, 2014 - Thomson Reuters ONE
Ignyta to Participate in Precision Medicine Panel Discussions with Other Thought Leaders 7:00 a.m. Sept. 17, 2014 - BusinessWire - BZX
Event Schedules, Survey Findings, Regulatory Filings, and Market Activity - Research Reports on Amgen, Biogen Idec, Salix, Covidien and Shire 8:50 a.m. Sept. 15, 2014 - PR Newswire - PRF
Health Care Sector Stocks Technical Review - Ampio Pharma, InterMune, Biogen Idec, Hologic, and CareFusion Corp. 8:40 a.m. Sept. 15, 2014 - PR Newswire - PRF
Critical Alerts For U.S. Bancorp, Nuverra Environmental Solutions, Biogen, Deere and Philip Morris International Released By InvestorsObserver 9:31 a.m. Sept. 12, 2014 - PR Newswire - PRF
Detailed Results from Biogen Idec and AbbVie’s Pivotal Phase 3 Decide Study Further Define the Efficacy and Safety Profile of ZINBRYTA™ (Daclizumab High-Yield Process) 7:30 a.m. Sept. 12, 2014 - BusinessWire - BZX
New Data from ENDORSE Show Positive Results Continued over Five Years with TECFIDERA® (Dimethyl Fumarate) in a Wide Range of Multiple Sclerosis Patients 7:30 a.m. Sept. 11, 2014 - BusinessWire - BZX
PLEGRIDY™ (Peginterferon Beta-1a) Two-Year Data Confirm Maintenance of Efficacy and Safety in Multiple Sclerosis Patients 7:30 a.m. Sept. 11, 2014 - BusinessWire - BZX
New International Survey Finds MS Patients and Neurologists View Communication Positively, Yet Struggle to Discuss Key MS Symptoms 7:00 a.m. Sept. 10, 2014 - BusinessWire - BZX

Newer

Older

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Globant Unleashes MuleSoft AI Pod for Faster Integration

Unlocking the AI Puzzle: Webinar Speed Dials You ever swim through a mash-up of tech lingo that makes you feel like you're trudging through waist-high molasses? Well, Saddle up because that's exactly where Globant's new MuleSoft AI Pod is heading. Through Glob.AI, they're going all in on turning what used to take months into mere weeks—finally, right? In the business of...

Nanochon Tests Innovative Knee Implant in Human Trial

Mending Knees with New Tech: The Chondrograft™ Debut Picture this: Nanochon's Chondrograft™ just hit the ground running. They've got a bite out of the future by diving headfirst into their First-in-Human (FIH) clinical study. This ain't your grandma's knee replacement talk. This is about changing the game for those knee cartilages that let out a groan every time you...

Honoring Dr. Drew's Impact on Blood Banking History

Legacy of Dr. Charles R. Drew Comes Alive Here's one for the books: a legacy that's still saving lives 85 years after it began. Dr. Charles R. Drew, the mastermind behind blood banking, is getting his due respect with a documentary called Iconic Excellence. No fluff here—this film unveils how the man's breakthroughs during World War II laid down the bedrock of modern...

Mohegan Sun's Star-Studded 30th Year Bash: Details Inside

Mohegan Sun Hits the Big 3-0 with a Bang When a casino decides to throw a party, you already know they spare no expense. Mohegan Sun's hitting the big thirty this October, and they've got a lineup that screams celebration. This isn’t just about a glossy red carpet or celebrity sightings, folks. It’s about a milestone that reflects years of stellar entertainment,...

Triskell Debuts in Gartner's 2026 Magic Quadrant

Triskell Software Makes Its Mark Kicking off September 2026 with a bang, Triskell Software finds itself on the illustrious 2026 Gartner Magic Quadrant for Adaptive Project Management and Reporting (APMR). This marks the first time the Madrid-based company nabs a spot here, and it's a significant feather in their cap. Just think, out of the 11 vendors invited to this...

Codoxo Snags 2026 Award for AI Payment Innovation

Revolutionizing Healthcare Payment with AI Ah, healthcare and payments—two things that can make even the most patient folks lose their cool. But here comes Codoxo, shaking up this landscape with its Point Zero Payment Integrity solution, and someone's finally giving them the nod they deserve. For those of us who have been in the game for a while, this announcement is...

Nonprofit Option Rises for Specialty Physicians

Reimaging Choices for Specialty Physicians In the whirlwind of healthcare, specialty physicians often find themselves between a rock and a hard place. The traditional paths are either hug a major health system or auction off to private equity, each option chaining them to systems more interested in the balance sheet than in patient care. But now, a third door opens. One...

TELUS Digital Shakes Up Dreamforce with Exclusive Session

What's Cooking at Hotel Zetta? Ever see a company shake up an event like TELUS Digital is about to at Dreamforce 2026? Instead of the usual booth schmooze-fest at Moscone Center, these folks are camping at Hotel Zetta with a packed 'boutique' agenda. From September 15–16, they're rolling out serious insider sessions for the big brains in financial services, education,...

Mitrade EU Enhances Investor Safety with New Insurance

Mitrade's New Insurance: A Safety Net? Mitrade EU is amping up its game with some fresh insurance perks that catch the eye. They're slapping on some extra insolvency protection for clients trading under their CySEC license. Now that sounds like a financial shield anyone would want. Basically, they're adding another layer to the basic regulatory protections, and without...

Royal Mint Ventures Into the Final Frontier with Star Trek Coins

A Cosmic Coin Collection for the Ages The Royal Mint has stepped boldly into a realm where no coin has gone before—celebrating six decades of Star Trek with two new collectable 50p coins. For Star Trek fans who’ve followed the Enterprise to the furthest reaches of the galaxy, these coins aren’t just chump change—they’re keepsakes that capture a piece of sci-fi...